Bio Matrix Research

Bio-Matrix Research is a Japanese biotechnology company specializing in the discovery and development of therapeutic antibodies and diagnostic reagents. The company utilizes its proprietary phage display technology and extensive human antibody libraries to identify high-affinity monoclonal antibodies against a variety of disease targets. Their core business model includes both internal drug discovery programs and contract research services (CRO) for pharmaceutical and biotech partners worldwide. Bio-Matrix Research has a particular focus on oncology, with significant expertise in developing antibodies for targets like Glypican-3 and exploring antibody-drug conjugate applications. In addition to therapeutic development, the company provides specialized services in antibody humanization, affinity maturation, and the production of recombinant proteins.